loading...

Angioedema Quality of Life Score (AE-QoL)

Weller K; Groffik A; Magerl M; Tohme N; Martus P; Krause K; Metz M; Staubach P; Maurer M

ProQolid

Basic description

Developed in 2012

Authors

Weller K; Groffik A; Magerl M; Tohme N; Martus P; Krause K; Metz M; Staubach P; Maurer M

Copyright
MOXIE Company
Objective
To measure health-related quality of life (HRQoL) impairment in patients with recurrent angioedema
Therapeutic area
  • Cardiovascular Diseases
  • Skin and Connective Tissue Diseases
  • Immune System Diseases
Therapeutic indication
  • Hereditary Angioedema
  • Urticaria
Chronic spontaneous urticaria (csU), hereditary angioedema (HAE1&2)
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • German for Germany
Translations
23 translation(s)
Bibliographic reference(s) of the original questionnaire

Weller K, Groffik A, Magerl M, et al. Development and construct validation of the angioedema quality of life questionnaire. Allergy. 2012 Oct;67(10):1289-98 (Full Text Article)

Weller K, Magerl M, Peveling-Oberhag A, et al. The Angioedema Quality of Life Questionnaire (AE-QoL) - Assessment of Sensitivity to Change and Minimal Clinically Important Difference. Allergy. 2016 Aug;71(8):1203-9 (PubMed Abstract)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us